Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
HHS-OIG Highlights Anti-Fraud Safeguards of Refund, Discount Program Offered By Pharma to Alleviate Drug’s Cost
Lexology July 29, 2024
Highlights
The HHS-OIG released a favorable opinion regarding refunds and discounts offered to a treatment center for a drug manufactured by the corporation offering the assistance
The discounts offered under the proposed arrangement satisfy the “discount” safe harbor to the Anti-Kickback Statute (AKS)
The proposed arrangement included factors, the agency said, that limited risk under the AKS and the civil monetary penalty laws (CMP)
The U.S. Department of Health and Human Services’ Office of Inspector General (HHS-OIG) recently released OIG Advisory Opinion 24-04, a favorable opinion regarding the federal Anti-Kickback Statute (AKS) and civil monetary penalty laws (CMP) against beneficiary inducements as applied to a refund program and discount program. The program was offered by an affiliate of a drug...
Today's Sponsors
Today's Sponsor